Merck & Co., Inc. (MRK) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Merck & Co., Inc. (MRK:NYSE), powered by AI.

Current Price
$115.17
P/E Ratio
15.8
Market Cap
288.2B
Sector
Healthcare
What is the Merck & Co., Inc. stock price forecast?

Merck & Co., Inc. is currently trading at $115.17. View real-time AI analysis on Alpha Lenz.

What is Merck & Co., Inc. insider trading activity?

View the latest insider trading data for Merck & Co., Inc. on Alpha Lenz.

What is Merck & Co., Inc.'s P/E ratio?

Merck & Co., Inc.'s P/E ratio is 15.8.

Merck & Co., Inc.

NYSE · MRK
$115.17+0.27(+0.23%)Pre-marketNYSE regular session 09:30–16:00 ET
Ask about Merck & Co., Inc.'s future dividend policy...
Alpha Chat Insight

Merck & Co., Inc. trades at a P/E of 15.8 (fair value) with strong ROE of 36.9%. Operating margin of 34.0% indicates strong profitability.

Ask for details

Company Overview

Merck & Co., Inc. is a prominent player in the global pharmaceutical industry. It is primarily focused on the research, development, production, and marketing of drugs and vaccines. Known for its strong emphasis on innovative health solutions, Merck develops treatments and vaccines for a variety of diseases affecting humans and animals. Key areas include oncology, infectious diseases, diabetes, and vaccines, reflecting its commitment to addressing critical health challenges worldwide. The company operates in several strategic regions, exporting its advanced therapies to meet healthcare needs across different markets. With a robust pipeline of new products and significant investment in research and development, Merck plays a vital role in advancing medical breakthroughs and enhancing patient care. Beyond pharmaceuticals, Merck is involved in animal health, providing veterinary vaccines and services, contributing to agricultural productivity and food security. The company's ongoing efforts in groundbreaking research and public health initiatives underscore its importance in the healthcare sector.

CEOMr. Robert M. Davis J.D.
SectorHealthcare
IndustryDrug Manufacturers - General
Employees73,000

Company Statistics

FY 2025

Profile

$288.16BMarket Cap
$65.01BRevenue
0.00Shares Out
73,000Employees

Margins

74.80%Gross
44.77%EBITDA
34.01%Operating
32.41%Pre-Tax
28.09%Net

Valuation

15.79P/E
5.48P/B
4.43EV/Sales
11.10EV/EBITDA
23.31P/FCF

Growth (CAGR)

3.12%Rev 3Yr
9.38%Rev 5Yr
6.54%Op Inc 3Yr
31.85%Op Inc 5Yr
7.93%Net Inc 3Yr
20.90%Net Inc 5Yr

Returns

14.38%ROA
36.91%ROE
17.66%ROIC

Financial Health

$14.56BCash & Cash Equivalents
$69.64BNet Debt
159.90%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Merck & Co., Inc. (ticker: MRK) is a company listed on NYSE in the Healthcare sector (Drug Manufacturers - General). It has approximately 73,000 employees. Market cap is $288.2B.

The current price is $115.17 with a P/E ratio of 15.79x and P/B of 5.48x.

ROE is 36.91% and operating margin is 34.01%. Annual revenue is $65.0B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Merck & Co., Inc. (MRK) Stock Forecast 2026 $115.17 — Price, Financials & Analyst Targets | Alpha Lenz